Dates/times:
Monday, January 23 2017 at 09:00 AM (Get Tickets)
Location:
The Leela Mumbai
Andheri Kurla Road, Sahar Village, Andheri-Kurla Road
Mumbai, CA 94539
Event Description:
Overview:
Quality control and related contract laboratories are considered at high risk because after testing and approval, drug products and Active Pharmaceutical Ingredients (APIs) are released to the market without further check. That's the reason why the FDA and other agencies put highest emphasis on inspections of QC laboratories. Even though cGMP regulations have been in place since long time, the large number of QC related 483's and warning letters demonstrate that companies have problems with implementation.
This two day interactive in-person seminar will provide participants the regulatory background and guidelines through all critical areas of GMP compliance. This course helps attendees understand the latest requirements and also provides them templates and examples to develop inspection ready documentation.
Practical examples and interactive exercises will be dispersed into and between the presentations while 50% of the total time will be dedicated to practical sessions. During the seminar, participants will work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned from the course.
Learning Objectives:
Learn about the regulatory background and GMP requirements for quality control and contract laboratories.
Understand and be able to explain your company's quality plan or laboratory compliance master plan.
Understand the difference between GMP and non-GMP laboratories.
Learn how to develop inspection ready documentation.
Be able to train others in your organization on GMP requirements.
Learn how to avoid and/or respond to the FDA inspectional observations and warning letters.
Complimentary Hand-outs:
For easy implementation, attendees will receive free access to "Laboratory Compliance Package" as Web download.
This package includes 46 SOPs, a compliance master plan, checklist and templates that help to implement GMP requirements in laboratories
50-Page primer: FDA GMP Compliance in Analytical Laboratories
Laboratory Compliance Master Plan
Worksheet - Laboratory Audits
Following Standard Operating Procedures:
Who Should Attend:
This seminar will be beneficial to the following personnel in FDA regulated laboratories:
Analysts and lab managers
QA managers and personnel
Validation specialists
Regulatory affairs
IT professionals
Human resources (HR) managers and staff
Training departments
Documentation department
Consultants& teachers
Agenda:
Day 1 Schedule:
Lecture 1: FDA Regulations and Requirements Overview
FDA 21 CFR Part 211 and 21 CFR Part 11
Most frequently cited FDA 483s and warning letters
Requirements overview from sampling to archiving
Quality system requirements, e.g., ICH Q10
The concept and practice of risk based compliance
Lecture 2: Planning for quality and cGMP compliance
Developing and using a validation master plan
Scope, objectives and key elements of the master plan
Developing and using FDA compliant SOPs
Using templates to generate inspection ready documentation
Planning for efficiency cost-effectiveness
Lecture 3: Calibration and Qualification of Laboratory Equipment
FDA requirements
USP chapter <1058> for instrument qualification
Going through examples for qualification steps(DQ, IQ, OQ, PQ)
SOPs and deliverables for three instrument categories
Developing calibration and qualification protocols
Lecture 4: Equipment Maintenance and Change control
Preventive maintenance; tasks, documentation
Planned and unplanned changes
Changing hardware, firmware, documentation
Definition and handling of like-for-like changes.
Requalification: time and event based
Lecture 5: Validation of Laboratory Computer Systems
Going through the new GAMP® guide: "A Risk based Approach to Laboratory Computerized Systems"
Going through a complete laboratory computer system validation from beginning to end
Integration the GAMP® guide with USP <1058>
Periodic evaluation to reduce revalidation efforts
Revalidation: why, what, when
Lecture 6: Validation of Analytical Methods and Procedures
Parameters and tests according to ICH Q2
Developing a validation plan, protocols and a report
Setting acceptance criteria for different applications
Verification of compendia methods according to USP <1226>
Transfer of analytical procedures according to the new USP <1224>
Day 2 Schedule:
Lecture 1: Sample Testing: Preparation, conduct, documentation
Preparing the equipment
Setting specifications and acceptance criteria
Documentation of test results
Review and approval
Not to forget: Review of electronic audit trail
Lecture 2: Handling out of specification (OOS) test results
Going through the FDA OOS guide
Learning from recent FDA warning letters
Going through an OOS checklist
Using out of trend (OOT) data to avoid OOS results
Documentation and follow-up: root cause, corrective action plan, preventive action plan
Lecture 3: Quality assurance of reference standards and other supplies
Supplier qualification vs. sample testing
Selection and assessment of suppliers
Retesting of materials
Preparing working standards from reference standards
Correct labeling of chemicals
Lecture 4: Training for GMP compliance
FDA requirements
identification of training needs
Developing a training plan
Making GMP training interesting
Documenting effectiveness of training
Lecture 5: Ensuring Integrity of Raw Data and Other records
FDA Part 11 and EU-PIC/S Annex 11 requirements
Definition of Raw Data: Electronic vs. paper
Acquisition and recording of raw data
The importance of electronic audit trail
Archiving of electronic records for 'ready retrieval'
Lecture 6: Internal audits in preparation for FDA inspection
Scheduling of audits
FDA Inspections as model for laboratory audits
Going through a typical FDA laboratory inspection
Responding to Typical inspectional/audit deviation
How to avoid FDA 483s and warning letters
Lecture 7: Wrap up - Final questions and answers
Speaker:
Dr. Ludwig Huber
Chief Advisor - Global FDA compliance, Agilent Technologies
Chairman, presenter and panel discussion member at US-FDA Industry Training sessions and conferences
Served as team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on Laboratory Systems.
Presenter of the Year of the Institute for Validation and Technology
Director and chief editor of www.labcompliance.com, the global on-line resource for validation and compliance issues for laboratories.
Author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems"
Location: Mumbai, India Date: January 23rd and 24th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: The Leela Mumbai
Address: Andheri Kurla Road, Sahar Village, Andheri-Kurla Road, Mumbai, Maharashtra 400059
Price:
Register now and save ₹ 2000. (Early Bird)
Price: ₹ 14,000 (Seminar for one Delegate)
Until December 10, Early Bird Price: ₹ 14,000 from December 11 to January 21, Regular Price: ₹ 16,000
Registration Details:
NetZealous - GlobalCompliancePanel
NetZealous Services India Pvt. Ltd.
Gururaya Mansion, 759 to 764, 8th Main road, J.P.Nagar,
Bangalore - 560078 Karnataka, INDIA
Phone: 1800 425 9409
Fax: 080-25149544
customersupport@globalcompliancepanel.com
http://www.globalcompliancepanel.in/
Registration Link - http://www.globalcompliancepanel.in/control/GMP-for-quality-control
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanelindia